Decreased persistence to cholinesterase inhibitor therapy with concomitant use of drugs that can impair cognition.
about
Persistence and adherence with dementia pharmacotherapy: relevance of patient, provider, and system factorsCompliance assessment of ambulatory Alzheimer patients to aid therapeutic decisions by healthcare professionals.Donepezil Adherence, Persistence and Time to First Discontinuation in a Three-Year Follow-Up of Older People.Progress update: Pharmacological treatment of Alzheimer's disease.Exploration of 100 commonly used drugs and supplements on cognition in older adultsSelf-Reported Medication Adherence Barriers Among Ambulatory Older Adults with Mild Cognitive Impairment.Simultaneous usage of dementia medications and anticholinergics among Asians and Pacific Islanders.Racial and Ethnic Differences in Initiation and Discontinuation of Antidementia Drugs by Medicare Beneficiaries.Adherence and Tolerability of Alzheimer's Disease Medications: A Pragmatic Randomized Trial.Community Pharmacists' Knowledge Regarding Donepezil Averse Effects and Self-Care Recommendations for Insomnia for Persons with ADAdherence, persistence and continuation with cholinesterase inhibitors in Alzheimer's disease.A 2-year prospective cohort study of antidementia drug non-persistency in mild-to-moderate Alzheimer's disease in Europe : predictors of discontinuation and switch in the ICTUS study.
P2860
Q26997299-E3BF9CFE-CB47-4A56-80EE-904C92B146ABQ33652896-AD619426-573E-4A20-903F-1924756391D0Q36650679-33FAA7D7-BB3E-4904-B2B1-B855DEA54393Q37129735-A4250121-6E79-464C-A7FC-76C0A67726D2Q37297346-3E0DAE76-34C5-4AE9-8A3C-53F059B9B497Q38739165-526BE691-8068-4041-9434-042328795DE2Q39226012-6EC99825-DD18-4B40-827A-0A19350B593CQ39466063-3272DB7C-1C99-4D5F-B829-C443216C9F67Q40291746-F238282E-FC6C-4998-87A6-5226EBACCD88Q42367995-9FBAFA67-4D7A-4EBA-A016-DEAD9584E166Q44281582-56B068AE-CA94-4B53-8A31-F298CCCF85E7Q44716353-75A199F0-2138-42BF-A7E1-96C1E2379B4E
P2860
Decreased persistence to cholinesterase inhibitor therapy with concomitant use of drugs that can impair cognition.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh-hant
name
Decreased persistence to choli ...... ugs that can impair cognition.
@en
Decreased persistence to choli ...... ugs that can impair cognition.
@nl
type
label
Decreased persistence to choli ...... ugs that can impair cognition.
@en
Decreased persistence to choli ...... ugs that can impair cognition.
@nl
prefLabel
Decreased persistence to choli ...... ugs that can impair cognition.
@en
Decreased persistence to choli ...... ugs that can impair cognition.
@nl
P2860
P1433
P1476
Decreased persistence to choli ...... rugs that can impair cognition
@en
P2093
Stephen J Kogut
Susan M Abughosh
P2860
P304
P356
10.1592/PHCO.2005.25.12.1729
P407
P577
2005-12-01T00:00:00Z